Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apellis Pharmaceuticals Inc COM | 11,111,111 | 11,111,111 | 0 | $422.67M | $665.11M | 9.19% | +$242.44M |
| United Therapeutics Corporation(UTHR) | 2,852,500 | 2,858,888 | +6,388 | $644.29M | $628.64M | 8.68% | -$15.65M |
| Ascendis Pharma A/SADR(ASND) | 3,670,000 | 3,755,555 | +85,555 | $343.66M | $473.01M | 6.53% | +$129.35M |
| argenx SEADR(ARGX) | 1,000,000 | 1,234,567 | +234,567 | $491.63M | $469.67M | 6.49% | -$21.96M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,555,000 | 1,888,888 | +333,888 | $227.09M | $437.05M | 6.04% | +$209.96M |
| Sarepta Therapeutics, Inc.(SRPT) | 4,025,000 | 4,344,444 | +319,444 | $487.91M | $418.93M | 5.79% | -$68.98M |
| BioMarin Pharmaceutical Inc.(BMRN) | 3,850,000 | 4,300,000 | +450,000 | $340.65M | $414.61M | 5.73% | +$73.96M |
| Spdr Series Trust - S&p BiotechETF ST STR SP BIOT | 0 | 4,444,444 | +4,444,444 | $0 | $396.84M | 5.48% | +$396.84M |
| Amicus Therapeutics Inc COM | 27,400,000 | 27,400,000 | 0 | $333.18M | $388.81M | 5.37% | +$55.62M |
| Cerevel Therapeutics Hldng | 955,555 | 7,555,555 | +6,600,000 | $20.86M | $320.36M | 4.42% | +$299.50M |
| Krystal Biotech, Inc.(KRYS) | 2,565,555 | 2,565,555 | 0 | $297.60M | $318.28M | 4.40% | +$20.68M |
| Mirati Therapeutics Inc | 6,666,666 | 4,886,840 | -1,779,826 | $290.40M | $287.10M | 3.97% | -$3.30M |
| Cymabay Therapeutics Inc | 10,300,000 | 11,111,111 | +811,111 | $153.57M | $262.44M | 3.63% | +$108.87M |
| Xenon Pharmaceuticals Inc.(XENE) | 4,900,000 | 5,666,666 | +766,666 | $167.38M | $261.01M | 3.61% | +$93.62M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 1,011,111 | 1,111,111 | +100,000 | $179.07M | $212.68M | 2.94% | +$33.61M |
| Intra-Cellular Therapies Inc | 0 | 2,255,555 | +2,255,555 | $0 | $161.54M | 2.23% | +$161.54M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 1,999,999 | 2,580,000 | +580,001 | $114.00M | $155.81M | 2.15% | +$41.81M |
| Kymera Therapeutics, Inc.(KYMR) | 3,855,000 | 3,775,000 | -80,000 | $53.58M | $96.11M | 1.33% | +$42.53M |
| Structure Therapeutics IncADR | 1,000,000 | 2,333,333 | +1,333,333 | $50.42M | $95.11M | 1.31% | +$44.69M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 2,555,555 | 4,222,222 | +1,666,667 | $37.11M | $91.24M | 1.26% | +$54.14M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 11,550,000 | 13,050,000 | +1,500,000 | $81.77M | $78.17M | 1.08% | -$3.60M |
| Iovance Biotherapeutics, Inc.(IOVA) | 6,700,000 | 6,700,000 | 0 | $30.48M | $54.47M | 0.75% | +$23.99M |
| Roivant Sciences Ltd.(ROIV) | 4,651,162 | 4,651,162 | 0 | $54.33M | $52.23M | 0.72% | -$2.09M |
| Kura Oncology, Inc.(KURA) | 2,980,000 | 2,980,000 | 0 | $27.18M | $42.85M | 0.59% | +$15.67M |
| Spyre Therapeutics, Inc.(SYRE) | 11,458 | 1,839,138 | +1,827,680 | $140.4K | $39.58M | 0.55% | +$39.44M |
| Karuna Therapeutics Inc | 0 | 125,000 | +125,000 | $0 | $39.56M | 0.55% | +$39.56M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,250,000 | 1,260,900 | +10,900 | $25.61M | $37.79M | 0.52% | +$12.18M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 565,000 | 1,130,000 | +565,000 | $15.18M | $34.58M | 0.48% | +$19.40M |
| Marinus Pharmaceuticals Inc | 3,150,000 | 3,150,000 | 0 | $25.36M | $34.24M | 0.47% | +$8.88M |
| MannKind Corporation(MNKD) | 9,000,000 | 9,000,000 | 0 | $37.17M | $32.76M | 0.45% | -$4.41M |
| Soleno Therapeutics Inc | 0 | 785,000 | +785,000 | $0 | $31.60M | 0.44% | +$31.60M |
| Verrica Pharmaceuticals Inc.(VRCA) | 2,954,064 | 3,999,999 | +1,045,935 | $11.48M | $29.28M | 0.40% | +$17.80M |
| Immunogen Inc | 0 | 875,000 | +875,000 | $0 | $25.94M | 0.36% | +$25.94M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 4,535,000 | 4,535,000 | 0 | $21.72M | $25.62M | 0.35% | +$3.90M |
| Merus N V | 444,444 | 888,888 | +444,444 | $10.48M | $24.44M | 0.34% | +$13.96M |
| Tourmaline Bio Inc | 0 | 868,407 | +868,407 | $0 | $22.73M | 0.31% | +$22.73M |
| Avidity Biosciences Inc | 2,510,000 | 2,510,000 | 0 | $16.01M | $22.72M | 0.31% | +$6.70M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 1,500,000 | 350,000 | -1,150,000 | $53.48M | $16.74M | 0.23% | -$36.74M |
| Fennec Pharmaceuticals Inc.(FENC) | 1,200,000 | 1,200,000 | 0 | $9.01M | $13.46M | 0.19% | +$4.45M |
| Nuvalent Inc | 812,500 | 178,921 | -633,579 | $37.35M | $13.17M | 0.18% | -$24.18M |
| Taysha Gene Therapies, Inc.(TSHA) | 3,925,000 | 4,355,555 | +430,555 | $12.40M | $7.71M | 0.11% | -$4.69M |
| Whitehawk Therapeutics, Inc.(WHWK) | 2,849,402 | 2,849,402 | 0 | $13.79M | $5.76M | 0.08% | -$8.04M |
| AKERO THERAPEUTICS ORDCommon | 555,555 | 0 | -555,555 | $28.10M | $0 | — | -$28.10M |
| HORIZON THERAPEUTICS PLCCommon | 7,000,000 | 0 | -7,000,000 | $809.83M | $0 | — | -$809.83M |
| IKENA ONCOLOGY INCCommon | 1,640,000 | 0 | -1,640,000 | $7.10M | $0 | — | -$7.10M |
| IO BIOTECH INCCommon(IOBTQ) | 2,055,883 | 0 | -2,055,883 | $2.84M | $0 | — | -$2.84M |
| PMV PHARMACEUTICALS INCCommon(PMVP) | 3,000,000 | 0 | -3,000,000 | $18.42M | $0 | — | -$18.42M |
| SEAGEN INCCommon | 1,759,606 | 0 | -1,759,606 | $373.30M | $0 | — | -$373.30M |
| SERES THERAPEUTICS INCCommon(MCRB) | 2,500,000 | 0 | -2,500,000 | $5.95M | $0 | — | -$5.95M |
| TALARIS THERAPEUTICS INCCommon | 500,000 | 0 | -500,000 | $1.41M | $0 | — | -$1.41M |
| TANGO THERAPEUTICS INCCommon(TNGX) | 2,222,222 | 0 | -2,222,222 | $25.02M | $0 | — | -$25.02M |